10x Genomics, Inc.
TXG
Pozycja w akcjach
#2176
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012... Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Cena akcji
$72.10
Kapitalizacja rynkowa
$9.39B
Zmiana (1 dzień)
3.16%
Zmiana (1 rok)
448.71%
Kraj
US
Handel 10x Genomics, Inc. (TXG)
Kategoria
Healthcare
Przychody dla 10x Genomics, Inc. (TXG)
Przychody w Jun 2026 TTM: $616.91M
Według najnowszych raportów finansowych 10x Genomics, Inc., obecny przychód firmy (TTM) wynosi $616.91M. W roku 2024 firma osiągnęła przychód w wysokości $610.79M spadek w porównaniu do przychodu z roku 2023, który wynosił $618.73M. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy 10x Genomics, Inc. od 2017 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $616.91M | -4.03% |
| 2025 | $642.82M | 5.25% |
| 2024 | $610.79M | -1.28% |
| 2023 | $618.73M | 19.81% |
| 2022 | $516.41M | 5.28% |
| 2021 | $490.49M | 64.13% |
| 2020 | $298.85M | 21.53% |
| 2019 | $245.89M | 68.06% |
| 2018 | $146.31M | 105.83% |
| 2017 | $71.09M | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| $20.24B | 3,181.35% |
US
|
|
| $184.56M | -70.08% |
AU
|
|
| $14.37B | 2,229.61% |
US
|
|
| $1.43B | 132.13% |
US
|
|
| - | - |
US
|
